Medical Research News

RSS

Signaling pathway within brain cells regulates sleep

A good night's sleep can work wonders for both mind and body. But what is it that determines how much we need to sleep, and what can cause us to sleep more deeply?

12 Dec 2022

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

Cambridge scientists have created a comprehensive tool for predicting an individual's risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive the appropriate testing while reducing unnecessary – and potentially invasive – testing for those at very low risk.

12 Dec 2022

What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

Researchers explored the indicators of long COVID symptoms.

12 Dec 2022

Research reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potential

Researchers developed a screening platform and identified molecules with anti-CoV activity.

12 Dec 2022

Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Many children with ALL have a good outcome of their disease. After two years of chemotherapy treatment, nine out of ten children are cured. But some children have a more aggressive form of the disease.

12 Dec 2022

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Researchers compared the efficiency of bioengineered soluble ACE-2 concerning brain protection during COVID-19.

12 Dec 2022

$Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction$

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

From AstraZeneca 12 Dec 2022

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Researchers modeled the benefit-risk of Moderna’s COVID-19 mRNA-1273 vaccine.

12 Dec 2022

Knowledge and attitudes to mpox among GBMSM in Australia

Researchers presented the results of a cross-sectional survey done in Australia between August and September 2022.

12 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Researchers evaluated the effects of hybrid immunity and booster vaccination on Omicron sublineages.

12 Dec 2022

Multiscale landscaping of droplet wettability and mobility of N95 masks

Researchers characterized the wettability of fibrous layers of N95 respirators or face masks using contact angle goniometers.

12 Dec 2022

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

Researchers evaluated the incidence of COVID-19 rebound among SARS-CoV-2 -positive patients treated with oral antiviral drugs such as nirmatrelvir-ritonavir combination and molnupiravir.

12 Dec 2022

ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

The COVID-19 global pandemic remains a major public health challenge. ASCOT researchers aim to discover which treatments are most effective in patients hospitalized with COVID-19.

12 Dec 2022

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

Researchers investigates the impact of the COVID-19 pandemic on pancreatic cancer services in England.

11 Dec 2022

Reports of Mpox disease following recent vaccination

The risk of infection and development of severe symptoms for Mpox remains, even after vaccination

11 Dec 2022

Severe COVID-19 causes aging-like changes in the human brain

Severe COVID-19 triggers aging-like changes in the brain's frontal cortex region that results in cognitive deficits.

11 Dec 2022

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Researchers construct a recombinant host-range restricted vaccinia virus Ankara (rMVAs) expressing the spike proteins of several SARS-CoV-2 variants.

11 Dec 2022

How convergent evolution is creating new COVID-19 waves

Researchers detail the unique evolutionary trajectory of SARS-CoV-2, with a focus on its unprecedented scale in 2022.

11 Dec 2022

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Researchers investigate whether the risk of new-onset type 1 diabetes is elevated by SARS-CoV-2 infections among children living in Denmark.

11 Dec 2022

Medical Research News

Signaling pathway within brain cells regulates sleep

Cambridge scientists develop a comprehensive tool for predicting individual's risk of prostate cancer

What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

Research reveals the assembly dynamics of nucleocapsid protein condensates can be regulated by small molecules with therapeutic potential

Extra year of chemotherapy lowers the risk of cancer recurrence in children with Ikaros leukemia

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Knowledge and attitudes to mpox among GBMSM in Australia

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Multiscale landscaping of droplet wettability and mobility of N95 masks

What is the incidence of viral rebound after treatment with nirmatrelvir-ritonavir and molnupiravir?

ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

How the COVID-19 pandemic impacted the treatment pancreatic cancer patients

Reports of Mpox disease following recent vaccination

Severe COVID-19 causes aging-like changes in the human brain

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

How convergent evolution is creating new COVID-19 waves

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News